220 related articles for article (PubMed ID: 27187749)
1. Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
Shmagel KV; Saidakova EV; Shmagel NG; Korolevskaya LB; Chereshnev VA; Robinson J; Grivel JC; Douek DC; Margolis L; Anthony DD; Lederman MM
HIV Med; 2016 Sep; 17(8):581-9. PubMed ID: 27187749
[TBL] [Abstract][Full Text] [Related]
2. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
[TBL] [Abstract][Full Text] [Related]
4. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Plankey MW; Grunfeld C; Tien PC
AIDS; 2017 Jan; 31(3):385-393. PubMed ID: 28081037
[TBL] [Abstract][Full Text] [Related]
5. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.
Medrano LM; Garcia-Broncano P; Berenguer J; González-García J; Jiménez-Sousa MÁ; Guardiola JM; Crespo M; Quereda C; Sanz J; Canorea I; Carrero A; Hontañón V; Muñoz-Fernández MÁ; Resino S;
AIDS; 2018 Jun; 32(9):1095-1105. PubMed ID: 29438197
[TBL] [Abstract][Full Text] [Related]
6. HCV coinfection of the HIV-infected patients with discordant CD4
Shmagel KV; Korolevskaya LB; Saidakova EV; Shmagel NG; Chereshnev VA; Margolis L; Anthony D; Lederman M
Dokl Biol Sci; 2017 Nov; 477(1):244-247. PubMed ID: 29299802
[TBL] [Abstract][Full Text] [Related]
7. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
8. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
[TBL] [Abstract][Full Text] [Related]
11. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
12. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
[TBL] [Abstract][Full Text] [Related]
13. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
[TBL] [Abstract][Full Text] [Related]
15. Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.
Jenabian MA; Mehraj V; Costiniuk CT; Vyboh K; Kema I; Rollet K; Paulino Ramirez R; Klein MB; Routy JP
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):254-62. PubMed ID: 26436613
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.
Sun B; Abadjian L; Monto A; Freasier H; Pulliam L
J Infect Dis; 2020 Jul; 222(3):396-406. PubMed ID: 32157304
[TBL] [Abstract][Full Text] [Related]
17. Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy.
Sitia G; De Bona A; Bagaglio S; Galli L; Paties CT; Uberti-Foppa C; Guidotti LG; Lazzarin A; Morsica G
Antivir Ther; 2006; 11(3):385-9. PubMed ID: 16759056
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
Pace FH; Ferreira LE; Silva AE; Ferraz ML
Rev Soc Bras Med Trop; 2012; 45(4):444-7. PubMed ID: 22930041
[TBL] [Abstract][Full Text] [Related]
19. Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women.
French AL; Grennan D; Daubert E; Seaberg EC; Peters M; Augenbraun M; Fischl M; Kassaye S; Franco R; Kuniholm M; Adimora AA; Workowski K; Weber KM
AIDS; 2021 Jul; 35(9):1433-1438. PubMed ID: 33710024
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
